Friedrich Stölzel
- Hematology top 1%
- Acute Myeloid Leukemia Research 54
- Hematopoietic Stem Cell Transplantation 29
- Chronic Myeloid Leukemia Treatments 12
- Genetics top 2%
- Myeloproliferative Neoplasms: Diagnosis and Treatment 12
- Mesenchymal stem cell research 9
- Oncology top 10%
- Cancer Research top 10%
- Emergency Medicine top 5%
- Hematological disorders and diagnostics 8
-
- Acute Lymphoblastic Leukemia research 11
-
- Bone and Joint Diseases 8
- Co-authors
- Martin BornhäuserGerhard EhningerMarkus SchaichChristoph RölligUwe PlatzbeckerBrigitte MohrFrank KroschinskyMichael Krämer
- Cited by
- HematologyGeneticsOncology
- Journals
- Journal of Clinical Oncology (2 papers)SHILAP Revista de lepidopterología (1 paper)Blood (25 papers)
- Partner nations
- GermanyUnited StatesItaly
In The Last Decade
Friedrich Stölzel
85 papers receiving 1.9k citations
Hit Papers
Peers
Comparison fields: 5 of 112
- Hematology 1.0k
- Genetics 553
- Oncology 409
- Cancer Research 215
- Emergency Medicine 99
Countries citing papers authored by Friedrich Stölzel
This map shows the geographic impact of Friedrich Stölzel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Friedrich Stölzel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Friedrich Stölzel more than expected).
Fields of papers citing papers by Friedrich Stölzel
This network shows the impact of papers produced by Friedrich Stölzel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Friedrich Stölzel. The network helps show where Friedrich Stölzel may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Friedrich Stölzel, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2026 | 0 | |
| 2 | 2025 | 6 | |
| 3 | 2024 | 3 | |
| 4 | 2024 | 3 | |
| 5 | 2024 | 3 | |
| 6 | 2024 | 17 | |
| 7 | 2023 | 4 | |
| 8 | Allogeneic Stem Cell Transplantation with Sequential Melphalan-Based Conditioning in AML: Residual Morphological Blast Count Determines the Risk of Relapse | 2022 | 3 |
| 9 | 2022 | 1 | |
| 10 | 2022 | 41 | |
| 11 | 2020 | 8 | |
| 12 | 2019 | 34 | |
| 13 | 2018 | 10 | |
| 14 | 2018 | 20 | |
| 15 | 2018 | 42 | |
| 16 | 2017 | 8 | |
| 17 | 2013 | 51 | |
| 18 | 2013 | 17 | |
| 19 | 2012 | 37 | |
| 20 | 2010 | 21 |
About Friedrich Stölzel
Friedrich Stölzel is a scholar working on Hematology, Genetics and Transplantation, having authored 92 papers that have together received 1.9k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (54 papers), Hematopoietic Stem Cell Transplantation (29 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (12 papers), Chronic Myeloid Leukemia Treatments (12 papers), Acute Lymphoblastic Leukemia research (11 papers), Mesenchymal stem cell research (9 papers), Hematological disorders and diagnostics (8 papers) and Bone and Joint Diseases (8 papers). The work is most often cited by research in Hematology (1.0k citations), Genetics (553 citations) and Oncology (409 citations). Friedrich Stölzel has collaborated with scholars based in Germany, United States and Italy. Frequent co-authors include Martin Bornhäuser, Gerhard Ehninger, Markus Schaich, Christoph Röllig, Uwe Platzbecker, Brigitte Mohr, Frank Kroschinsky, Michael Krämer, Malte von Bonin and Johannes Schetelig. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.